Biden Taps Diabetes Drug for Medicare Price Negotiation

A popular diabetes treatment and the blood thinner Eliquis are among the first drugs that will be targeted for price negotiations in effort to cut Medicare costs.[#item_full_content]

Related articles

You may also be interested in

Headline

Never Miss A Story

Get our Weekly recap with the latest news, articles and resources.
Cookie policy

We use our own and third party cookies to allow us to understand how the site is used and to support our marketing campaigns.